PLoS ONE · 2013 · 68 citations · 34 references
Life SciencesImmunologyPharmacologyCell SignalingImmunopathologyInflammationCytokine BiologyGastrointestinal InflammationInflammatory Bowel DiseaseInflammatory Cell SignalingInflammatory SignalingInterferon ResponsesCell ActivationColonic InflammationInflammatory Bowel Disease PathogenesisInflammatory Bowel Disease PathophysiologyInflammatory Bowel Disease TherapyPeptide Natural ProductsPi3k SignalingPi3k-akt Signaling Pathway
Crohn's disease is a common, chronic inflammatory bowel condition characterized by remission and relapse. Accumulating evidence indicates that activated T cells play an important role in this disease. In the present study, we aimed to examine the effect of beauvericin, a natural cyclic peptide, on 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced colitis in mice, which mimics Crohn's disease. Beauvericin significantly reduced weight loss, diarrhea and mortality, accompanied with notable alleviation of macroscopic and microscopic signs. In addition, this compound decreased serum levels of tumor necrosis factor (TNF)-α and interferon (IFN)-γ in a concentration-dependent manner in mice with experimental colitis. These effects of beauvericin are attributed to its inhibition on activated T cells. Flow cytometry and immunoblot assay data showed that beauvericin suppressed T-cell proliferation, activation and IFN-γ-STAT1-T-bet signaling and subsequently led to apoptosis of activated T cells by suppressing Bcl-2 and phosphorylated Bad as well as increasing cleavage of caspase-3, -9, -12 and PARP. Furthermore, inhibition of PI3K/Akt signaling, which was an upstream regulator of cell activation and survival in activated T cells, contributed to the effect of beauvericin. Overall, these results supported beauvericin as a novel drug candidate for the treatment of colonic inflammation mainly by targeting PI3K/Akt in activated T cells.
34
Akt Phosphorylation of BAD Couples Survival Signals to the Cell-Intrinsic Death Machinery
Sandeep Robert Datta, Henryk Dudek, Xu Tao et al. · Cell · 1997 · 5.7K citations · Full text
Andrea Alimonti, Caterina Nardella, Zhenbang Chen et al. · Journal of Clinical Investigation · 2010 · 356 citations · Full text